Patented biomarker for cardiac injury. 

Patented biomarker for cardiac injury. 

Study highlights speed of biomarker integration on Psyros POC platform

A collaborative research project between Prolight and St Thomas’ Hospital has demonstrated how quickly a cardiac biomarker assay for cMyC, can be transferred onto the Psyros™ point-of-care (POC) system. The study underscores the platform’s potential and its broader diagnostic applications beyond high-sensitive troponin.

cMyC (Cardiac Myosin-binding protein C)
cMyC (Cardiac Myosin-binding protein C)